Recent news highlights include Ensign Group's Q1 2026 earnings surpassing estimates and continued operational updates reflecting the company's financial and business performance.

• Ensign Group reported Q1 2026 earnings surpassing estimates, indicating ongoing operational performance improvements [N2].
• The company also reported Q4 2025 earnings surpassing estimates with income rising, reflecting positive financial results [N2].
• Ensign Group has been recognized in recent news as a strong growth and momentum stock, with a history of dividend increases for 23 consecutive years [N2].

Ensign Group's extensive network of skilled nursing and senior living facilities across multiple states, combined with its captive REIT owning a substantial real estate portfolio, provides diversified revenue streams. The company's localized management approach and portfolio company structure support operational improvements and growth through acquisitions. Participation in value-based care models and focus on quality ratings may enhance reimbursement opportunities. The company's history of dividend increases and recent earnings surpassing prior periods indicate operational strength and shareholder return potential.

The Ensign Group faces significant risks from regulatory changes, including Medicare and Medicaid reimbursement reductions and increased enforcement scrutiny, which could materially impact revenues and profitability. Staffing shortages and increased labor costs may pressure operating margins. Integration risks from acquisitions and potential legal liabilities pose operational challenges. The company's geographic concentration and reliance on government payors expose it to policy and economic risks. Changes in reimbursement methodologies and delays could adversely affect liquidity and financial results.

Ensign Group's moat is built on its localized operational model that empowers local leadership to customize healthcare services to community needs, fostering strong relationships with referral sources and patients. Its portfolio company structure enables efficient acquisition and integration of skilled nursing and senior living facilities. The captive REIT structure for its real estate portfolio provides financial flexibility and stable rental income through triple-net leases. The company's focus on quality care, demonstrated by improvements in CMS Five-Star Quality Ratings post-acquisition, supports its reputation and competitive positioning in the post-acute care market.

• Regulatory and Reimbursement Risks: Frequent changes in Medicare and Medicaid rules, reimbursement rates, and spending requirements could materially adversely affect revenues and financial condition.
• Operational and Compliance Risks: Increased government scrutiny, audits, and enforcement actions could result in fines, sanctions, or loss of licensure, negatively impacting operations.
• Labor and Staffing Risks: Competition for skilled nursing personnel and staffing shortages may increase labor costs and risk non-compliance with staffing regulations.
• Acquisition and Integration Risks: Challenges in successfully integrating acquired facilities and businesses could lead to operational disruptions and financial losses.
• Financial and Liquidity Risks: Delays in reimbursement, need for additional capital, and debt obligations could affect liquidity and ability to finance growth.
• Legal and Litigation Risks: Exposure to litigation and changes in arbitration enforceability may result in significant legal costs and settlements.

• The Ensign Group, Inc. is a holding company with independent subsidiaries providing skilled nursing, senior living, rehabilitative services, and ancillary businesses including mobile diagnostics and medical transportation across 17 states [S1].
• As of December 31, 2025, Ensign operated 373 skilled nursing and senior living facilities, with 253 under long-term lease arrangements and options to purchase 8 of those [S1].
• The company owns 158 real estate properties, including 120 operated and managed by Ensign and 38 leased to third-party operators [S1].
• Ensign's revenue is primarily derived from skilled nursing facilities, accounting for approximately 95.6% of total revenue in 2025; the remainder comes from real estate, senior living, and ancillary services [S1].
• Skilled nursing services are provided at 357 operations with 37,911 operational beds across multiple states, serving high-acuity patients recovering from various conditions [S1].
• Revenue from skilled services is generated from Medicaid (approximately 46.6%), Medicare (approximately 24.7%), managed care, commercial insurance, and private pay sources [S1].
• Senior living operations include 3,402 units across 47 operations, primarily generating revenue from private pay (about 55.5%) and some Medicaid and state programs [S1].
• Ancillary services include mobile diagnostics, digital x-ray, ultrasound, electrocardiograms, dialysis, respiratory, durable medical equipment, long-term care pharmacy, and patient transportation, though these are currently not significant contributors [S1].
• The company organizes subsidiaries into portfolio companies with local leadership empowered to tailor services to community needs, promoting a local business approach unique in the healthcare services industry [S1].
• Ensign has a captive REIT, Standard Bearer, owning and managing most of its real estate portfolio (152 of 158 properties), leasing properties under triple-net leases to subsidiaries and third parties [S1].
• Standard Bearer elected REIT status for U.S. federal income tax purposes starting in 2022 [S1].
• Ensign has a history of acquisitions, adding 145 facilities from 2021 to 2025, increasing skilled nursing beds and senior living units significantly [S1].
• The company focuses on organic growth, operating efficiencies, acquiring additional operations, expanding and renovating existing operations, and investing in complementary post-acute care businesses [S1].
• Ensign's skilled nursing facilities participate in CMS's Five-Star Quality Rating System, with a history of improving quality ratings post-acquisition despite recent CMS rating system changes [S1].
• For the quarter ended March 31, 2026, Ensign reported revenue of approximately $1.39 billion, net income of about $99.7 million, basic EPS of $1.73, and diluted EPS of $1.67 [S2].
• As of March 31, 2026, Ensign held cash and equivalents of approximately $539.5 million, short-term investments of about $55.7 million, current assets of $1.32 billion, and current liabilities of $848 million, resulting in a current ratio of 1.56 and a cash ratio of 0.7 [S2].
• Ensign's business is subject to extensive government regulation, including Medicare and Medicaid reimbursement rules, which represent a significant portion of revenue and are subject to frequent changes that can materially affect financial results [S2].
• Risks include regulatory changes, reimbursement rate reductions, increased enforcement and penalties, staffing shortages, litigation exposure, and challenges integrating acquisitions [S2].
• The company maintains a revolving credit facility with availability up to $600 million, maturing in April 2027, and holds mortgage loans insured with HUD totaling approximately $143.4 million as of December 31, 2025 [S1].
• Recent news highlights include Ensign Group's Q1 2026 earnings surpassing estimates, indicating operational performance updates [N2].
• Ensign Group's Q4 2025 earnings also surpassed estimates, with income rising, reflecting recent financial performance [N2].
• The company has been noted in recent news as a strong growth and momentum stock, with dividend increases for 23 consecutive years, indicating a history of shareholder returns [N2].